Melorheostosis: A Case Report in Pediatric Age Group
Keywords:
Sclerotic Bone Dysplasia, Cytology, Biopsy, FNACAbstract
Melorheostosis is a rare, benign, and disabling condition. It is a rare mesenchymal bone disease classified as a sclerotic bone dysplasia. We present this case because of its rarity and highlight the importance of Fine needle aspiration cytology which is a minimally invasive technique in ruling out the possibilities of osteomyelitis and malignancies. Fine Needle Aspiration Cytology (FNAC) negates the use of unwarranted biopsies. The disease is a benignentity with a generally chronic course and periods of exacerbation and remission. Therapy is symptomatic and is aimed at controlling pain.
Â
Â
DOI:Â 10.21276/APALM.1205
References
2)Resnick D. Diagnosis of bone and joint disorders. 3 rd ed, Vol. 6. Philadelphia, PA: WB Saunders; 1995;4410-3.
3) Greenspan A. Sclerosing bone dysplasias–a target-site approach. Skeletal Radiol. 1991; 20(8):561-583
4)Jain VK, Arya RK, Bharadwaj M, Kumar S Melorheostosis: Clinicopathological Features, Diagnosis, and Management. Orthopedics 2009;32(7)
5)Freyschmidt J. Melorheostosis: a review of 23 cases EurRadiol, 2001;11:474-479
6)McDermott M, Branstetter BF, Seethala RR. Craniofacial melorheostosis J Comput Assist Tomogr, 2008;32:825-827
7)Monte TC, Sala DR, Rubió JB, Bittermann V, Abelló JC. Melorheostosis, a Case Report Reumatol Clin.2011;7:346-8
8)Sureka B, Mittal MK, Udhaya KK, Sinha M, Mittal A, Thukral BB. Melorheostosis: Two atypical cases. Musculoskeletal Radiology 2014;24(2):192-195
9)Hoshi K, Amizuka N, Kurokawa T, Nakamura K, Shiro R, Ozawa H. Histopathological characterization of melorheostosis. Orthopedics. 2001; 24(3):273-277.
10)Hollick RJ, Black A, Reid D. Melorheostosis and its treatment with intravenous zoledronic acid. BMJ Case Rep. 2010 doi: 10.1136/bcr.04.2009.1757
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Rakesh Mehra, Richa Bhartiya, Pallavi Agrawal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).